RA
Robert F Apple
President and CEODirector

Robert F Apple insider trades: Antares Pharma (ATRS) stock buys and sales

President and CEO, Antares Pharma Last trade Feb 18, 2021 60 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
12
Open-market trades
since 2012
4
Companies
last trade 2021

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Robert reports to the SEC

Open-market buys and sales

12 trades reported on SEC Form 4, newest first

DateStockTypeValue
Feb 18, 2021ATRS↓ Sell$2.5M
Feb 10, 2021ATRS↓ Sell$427K
Dec 10, 2019ATRS↓ Sell$1.7M
Aug 21, 2018ATRS↓ Sell$161K
Apr 5, 2017ATRS↓ Sell$120K
Mar 18, 2016ATRS↑ Buy$43K
Jan 10, 2014ATRS↓ Sell$50K
Oct 14, 2013ATRS↓ Sell$111K
Jun 4, 2013ATRS↓ Sell$462K
May 6, 2013ATRS↓ Sell$40K
Jan 8, 2013ATRS↓ Sell$100K
Dec 4, 2012ATRS↓ Sell$100K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Robert F Apple's insider trades

Robert F Apple is President and CEO at Antares Pharma (ATRS). Since Dec 4, 2012, Robert has reported 1 open-market purchase worth $43K and 11 sales worth $5.8M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (37 filings), shares withheld for taxes (24 filings), option exercises (14 filings), shares returned to the company (3 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ATRS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.